Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H7N7O2S |
Molecular Weight | 277.263 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C=NC(=C1SC2=NC=NC3=C2N=CN3)[N+]([O-])=O
InChI
InChIKey=LMEKQMALGUDUQG-UHFFFAOYSA-N
InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)
Molecular Formula | C9H7N7O2S |
Molecular Weight | 277.263 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:11:20 UTC 2023
by
admin
on
Fri Dec 15 15:11:20 UTC 2023
|
Record UNII |
MRK240IY2L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
NBK548332
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
128099
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
WHO-VATC |
QL04AX01
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
NDF-RT |
N0000000233
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
NDF-RT |
N0000008065
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
WHO-ATC |
L04AX01
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
NCI_THESAURUS |
C574
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.1
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
2.4
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
NDF-RT |
N0000175712
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
NCI_THESAURUS |
C1556
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7120
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
269
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
DB00993
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
CHEMBL1542
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
DTXSID4020119
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
1256
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | RxNorm | ||
|
m2165
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | Merck Index | ||
|
7084
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
Azathioprine
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
SUB05647MIG
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
100000091475
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
MRK240IY2L
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
1291
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
D001379
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
MRK240IY2L
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
2265
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
AZATHIOPRINE
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
207-175-4
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
446-86-6
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
39084
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
AZATHIOPRINE
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | Description: A pale yellow powder; odourless. Solubility: Practically insoluble in water; very slightly soluble in ethanol (~750 g/l) TS; sparingly soluble in dilute mineral acids;soluble in dilute solutions of alkali hydroxides. Category: Immunosuppressive drug. Storage: Azathioprine should be kept in a well-closed container, protected from light. Additional information: Azathioprine decomposes in strong solutions of alkali hydroxides. CAUTION: Azathioprine must be handled with care, avoiding contact with the skin and inhalation of airborne particles. Definition: Azathioprine contains not less than 98.0% and not more than 101.5% of C9H7N7O2S, calculated with reference to the dried substance. | ||
|
1046001
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY | |||
|
C290
Created by
admin on Fri Dec 15 15:11:21 UTC 2023 , Edited by admin on Fri Dec 15 15:11:21 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
USP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
SALT/SOLVATE -> PARENT | |||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
Scientific Literature
|
||
|
METABOLITE ACTIVE -> PRODRUG |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|